PRKD3 and breast carcinoma: In addition, Immunofluorescence staining showed that p‐ERK1/2 (Thr202/Tyr204), p‐c‐MYC (Ser62) and c‐MYC were down‐regulated by knocking out PRKD3 in breast cancer cells (Figure 3A,B).